FDA weighs changes to policy on advisor conflicts

FDA may loosen its conflicts-of-interest rules governing scientists who serve on its advisory committees, Commissioner Margaret Hamburg said, in an attempt to ensure that it gets enough expert feedback on potential drug approvals and safety moves. Report